The Week in Review in Prescription Drug Pricing

Biggest upset in August? Serena beating the no. 2 seed or patients overcoming Big Pharma’s $205 million in lobbying spending? Game, set, mat

Welcome To The Week In Review.

  1. Patients Explain: “This Is A Game-changer.”

2. Congress Is Proud Of Drug Price Reforms

3. Big Pharma’s profiteering schemes

?BONUS: Tradeoffs dives into the Inflation Reduction Act and the next steps for implementing the new drug pricing law, as well as Big Pharma’s efforts in opposition. Give it a listen!

Have a great weekend, everyone!